Switch to:

Ra Pharmaceuticals ROCE %

: -53.77% (As of Dec. 2019)
View and export this data going back to 2016. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ra Pharmaceuticals's annualized ROCE % for the quarter that ended in Dec. 2019 was -53.77%.


Ra Pharmaceuticals ROCE % Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ra Pharmaceuticals Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
ROCE % Premium Member Only -125.97 -42.01 -57.42 -47.32 -45.08

Ra Pharmaceuticals Quarterly Data
Dec14 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
ROCE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -45.72 -39.74 -49.02 -44.18 -53.77

Ra Pharmaceuticals ROCE % Calculation

Ra Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2019 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2019 )  (A: Dec. 2018 )(A: Dec. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2019 )  (A: Dec. 2018 )(A: Dec. 2019 )
=-106.979/( ( (219.22 - 10.201) + (284.152 - 18.579) )/ 2 )
=-106.979/( (209.019+265.573)/ 2 )
=-106.979/237.296
=-45.08 %

Ra Pharmaceuticals's ROCE % of for the quarter that ended in Dec. 2019 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2019 )  (Q: Sep. 2019 )(Q: Dec. 2019 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2019 )  (Q: Sep. 2019 )(Q: Dec. 2019 )
=-151.312/( ( (308.938 - 11.666) + (284.152 - 18.579) )/ 2 )
=-151.312/( ( 297.272 + 265.573 )/ 2 )
=-151.312/281.4225
=-53.77 %

Note: The EBIT data used here is four times the quarterly (Dec. 2019) EBIT data.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Ra Pharmaceuticals  (NAS:RARX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Ra Pharmaceuticals ROCE % Related Terms


Ra Pharmaceuticals ROCE % Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)